InsiderTrades

Form 4 for TXG 10x Genomics, Inc.

Accepted 2022-01-05 00:00:00 ET · period of report 2022-01-03 · accession 0001567619-22-000621 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-01-05 2022-01-03 TXG Hindson Benjamin J. See Remarks, Dir S - Sale+OE $146.07 -41.7K 160.7K -21% -$6.09M
DM 2022-01-05 2022-01-03 TXG Hindson Benjamin J. See Remarks, Dir M - OptEx $71.42 +41.7K 162.8K +34% +$2.98M
DM 2022-01-05 2022-01-03 TXG Hindson Benjamin J. See Remarks, Dir M - OptEx $0.00 -41.7K 93.6K -31% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2022-01-03 S D 16,464 $145.43 183,588 D — — (F3) This transaction was executed in multiple trades at prices ranging from $144.89 to $145.88. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
2 Common Class A Common Stock 2022-01-03 S D 17,396 $146.29 166,192 D — — (F4) This transaction was executed in multiple trades at prices ranging from $145.89 to $146.8725. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
3 Common Class A Common Stock 2022-01-03 S D 2,906 $147.34 163,286 D — — (F5) This transaction was executed in multiple trades at prices ranging from $146.89 to $147.87. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
4 Common Class A Common Stock 2022-01-03 S D 2,000 $148.44 161,286 D — — (F6) This transaction was executed in multiple trades at prices ranging from $147.93 to $148.925. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
5 Common Class A Common Stock 2022-01-03 M A 39,582 $74.58 202,352 D — —
6 Common Class A Common Stock 2022-01-03 M A 2,084 $11.48 162,770 D — —
7 Common Class A Common Stock 2022-01-03 S D 2,300 $144.56 200,052 D — — (F2) This transaction was executed in multiple trades at prices ranging from $143.89 to $144.85. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
8 Common Class A Common Stock 2022-01-03 S D 600 $149.24 160,686 D — — (F7) This transaction was executed in multiple trades at prices ranging from $149.09 to $149.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
9 Derivative Stock Option (right to buy) 2022-01-03 M D 2,084 $0.00 31,250 D $11.48 · — to 2029-05-10 2,084 Class A Common Stock (F8) This option, originally for 100,000 shares, of which 68,750 shares have been exercised, vested as to 1/48th of the shares on May 1, 2019 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
10 Derivative Stock Option (right to buy) 2022-01-03 M D 39,582 $0.00 93,630 D $74.58 · — to 2030-04-21 39,582 Class A Common Stock (F9) This option, originally for 136,000 shares, of which 42,370 shares have been exercised, vested as to 1/48th of the shares on May 1, 2020 and 1/48th of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.